Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
日本語
English
Русский
中文
Español
Português
Deutsch
한국어
Français
Italiano
Türkçe
SILO
#3953
Silo Pharma, Inc. Common Stock
0.3
7
+5.71%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+5.71%
Aylık değişim
-2.63%
6 aylık değişim
-42.19%
Yıllık değişim
-72.59%
Önceki kapanış
0.3
5
Open
0.3
7
Bid
Ask
Low
0.3
7
High
0.3
7
Hacim
3
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
SILO
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
4.48 M
4.48 M
4.48 M
9.4 M
13.32 M
—
Valuation ratios
Enterprise value
72.01 K
85.37 K
2.11 M
1.59 M
5.27 M
9.06 M
Price to earnings ratio
-0.92
-0.75
-1.03
-0.62
-0.75
-3.14
Price to sales ratio
47.15
45.43
58.19
35.9
46.16
185.68
Price to cash flow ratio
-0.9
-0.85
-0.94
-0.5
-0.69
-2.99
Price to book ratio
0.14
0.65
0.19
0.12
0.18
1.14
Enterprise value to EBITDA ratio
—
-0.02
—
-0.31
-1
—
Profitability ratios
Return on assets %
-0.11
-0.23
-0.17
-0.18
-0.17
-0.76
Return on equity %
-0.14
-0.34
-0.26
-0.24
-0.22
-1.07
Return on invested capital %
-1 065.21
-1 935.59
-1 182.24
-1 388.27
-1 430.41
-5 936.51
Gross margin %
91.91
91.9
91.9
91.91
-14.77
260.94
Operating margin %
-5 603.63
-10.06 K
-6 069.68
-6 926.77
-6 388.16
-29.44 K
EBITDA margin %
-5 586.48
-10.04 K
-6 052.53
-6 913.05
-6 371.86
-29.38 K
Net margin %
-5 152.92
-9 600.69
-5 721.94
-6 681.24
-6 160.54
-28.16 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
7.91
4.29
4.73
6.07
8.7
23.8
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.31
-0.25
-0.37
-0.2
-0.1
-0.92
EBIT per share
-0.23
-0.49
-0.24
-0.2
-0.12
-1.06
EBITDA per share
-0.23
-0.49
-0.24
-0.2
-0.12
-1.06
Total debt per share
—
—
—
—
—
—
Cash per share
1.86
1.92
1.22
1
0.63
4.76
Net current asset value per share
1.92
1.93
1.25
1.01
0.66
4.86
Tangible book value per share
1.52
1.3
0.84
0.75
0.51
3.4
Working capital per share
1.68
1.48
0.99
0.85
0.58
3.9
Book value per share
1.58
1.37
0.89
0.78
0.54
3.58
Haberler
Silo Pharma株、100万ドルの自社株買いプログラムで急騰
Silo Pharma stock surges on $1M share buyback program
Silo Pharma、100万ドルの自社株買いプログラムを承認
Silo Pharma authorizes $1 million stock buyback program
Silo Pharmaの心的外傷後ストレス障害治療薬、日本で特許取得
Japan grants patent for Silo Pharma’s PTSD treatment
サイロ・ファーマ、SPC-15鼻スプレーの臨床試験でアルーセントとLOIを締結
Silo Pharma signs LOI with Allucent for SPC-15 nasal spray clinical trials
シロ・ファーマCEOワイスブラムが735ドル相当の自社株を購入
Silo Pharma CEO Weisblum buys $735 in company stock
Silo Pharma selects Allucent to support PTSD treatment IND submission
サイロ・ファーマ、ブロックチェーン資産投資にAlphaledger T12ファンドを選定